Business Context and Reporting Period
Company: Applied Optoelectronics, Inc. (AAOI)
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2026
Principal Executive Offices: Sugar Land, Texas
Reporting Period: The filing reports on a specific event occurring on March 12, 2026, regarding the amendment of an equity distribution agreement.
Key Financial Metrics and Transaction Details
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The financial data provided relates exclusively to a capital raising transaction:
- Agreement Type: Amendment No. 1 to Equity Distribution Agreement (At-the-Market Offering).
- Counterparties: Raymond James & Associates, Inc. and Needham & Company, LLC (Sales Agents).
- Revised Offering Cap: Increased from $250,000,000 to $500,000,000.
- Shares Sold to Date (as of March 12, 2026): 2,476,307 shares.
- Aggregate Proceeds Received to Date: Approximately $249,999,983.
- Remaining Capacity: Approximately $250,000,017.
- Compensation to Agents: 2% of the gross sales price of shares sold.
- Expense Reimbursement Cap: Up to $10,000 for registration/filing fees; up to $30,000 for termination-related legal expenses under specific conditions.
Material Changes Versus Prior Period
The primary material change reported is the expansion of the Company's equity distribution capacity:
- Capacity Increase: The total amount of shares the Company may offer and sell under the agreement was doubled from $250 million to $500 million.
- Utilization Status: The Company had effectively exhausted the original $250 million cap prior to this amendment, having sold shares with an aggregate offering price of approximately $250 million.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing indicates the Company intends to continue raising capital through "at-the-market" offerings. The Company retains the right to suspend offers and sales at any time and has no obligation to sell any shares.
Risks and Contingencies:
- Dilution: Future sales of shares under the agreement will result in dilution to existing shareholders.
- Market Conditions: Sales are subject to market conditions and the Company's discretion regarding timing and pricing.
- Termination: The agreement may be terminated by either the Company or the Sales Agents at any time.
- Liabilities: The Company has agreed to indemnify the Sales Agents against certain liabilities under the Securities Act.
Unusual Items: None reported in this filing.
Key Facts for Investor Verification
- Verify the current share price and the potential dilution impact of selling an additional $250 million worth of shares.
- Confirm the Company's current cash position and liquidity needs to understand the urgency of utilizing the remaining $250 million capacity.
- Review the full text of the Amendment (Exhibit 1.1) for specific termination clauses and conditions regarding the $30,000 expense reimbursement cap.
- Monitor future 8-K filings or quarterly reports for actual sales volumes and proceeds generated under the amended agreement.